Jay and jeanie schottenstein prize in cardiovascular science: Predicting cardiovascular illnesses for the 21st century, and the unpredictable ...

Antioxidants and Redox Signaling

Volumn 11, Issue 3, 2009, Pages 401-406

  Goldschmidt Clermont, Pascal J ^a  

^a UNIVERSITY OF MIAMI HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAC1 PROTEIN;

AGE DISTRIBUTION; ARTERY RECONSTRUCTION; ATHEROSCLEROSIS; CANCER GROWTH; CARDIOVASCULAR DISEASE; CELL REGENERATION; CHRONIC DISEASE; HUMAN; LIFE EXPECTANCY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL; TISSUE REPAIR; AWARDS AND PRIZES; COMPLICATION;

AWARDS AND PRIZES; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS;

EID: 58849086637     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2381     Document Type: Review

References (25)

1. Berkrot B, and Pierson R. Update 2-AstraZeneca's Crestor cuts deaths, heart attacks (Online). Reuters. http://www.reuters.com/article/ euRegulatoryNews/idUSN0933363620081109 2008, Nov. 9.
2. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, and Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
3. Dimmeler S and Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis. J Mol Med 82: 671-677, 2004. Review.
4. Dong C, Yoon W, and Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr 132: 2406S-2409S, 2002.
5. Foteinos G, Hu Y, Xiao Q, Metzler B, and Xu Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117: 1856-1863, 2008.
6. Goldschmidt-Clermont PJ. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am Heart J 146: S5-S12, 2003.
7. Goldschmidt-Clermont PJ, Creager MA, Losordo DW, Lam GK, Wassef M, and Dzau VJ. Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation 112: 3348-3353, 2005.
8. Goldschmidt-Clermont PJ and Peterson ED. On the memory of a chronic illness. Sci Aging Knowledge Environ 45: re8, 2003.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
10. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
11. Karra R, Vemullapalli S, Dong C, Herderick EE, Nevins JR, West M, Goldschmidt-Clermont PJ, and Seo D. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A 102: 16789-16794, 2005.
12. Kunz G, Liang G, Cuculi F, Gregg D, Vata K, Shaw L, Goldschmidt-Clermont PJ, Dong C, Taylor D, and Peterson ED. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 152: 190-195, 2006.
13. Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, and Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11: 245-258, 2007. Erratum in: Cancer Cell 115: 471, 2007.
14. Papaharalambus CA and Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17: 48-54, 2007. Review.
15. Podsypanina K, Du Y-C N, Jechlinger M, Beverly L, Hambardzumyan D, and Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321: 1841-1844, 2008.
16. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, Dong C, and Peterson ED. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50: 2243-2248, 2007.
17. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, and Taylor DA. Aging, vascular progenitor cell exhaustion and atherosclerosis. Circulation 108: 457-463, 2003.
18. Rossi DJ, Jamieson C, and Weissman I. Stems cells and the pathways to aging and cancer. Cell 132: 681-696, 2008.
19. Tsimikas S, Willerson J, and Ridker P. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47: C19-C31, 2006.
20. Urbich C, Kuehbacher A, and Dimmeler S. Role of micro-RNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588, 2008.
21. Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D, Harris M, Nelson S, Hale AB, Granger CB, Haines JL, Jones CJ, Crossman D, Seo D, Gregory SG, Kraus WE, Goldschmidt-Clermont PJ, and Vance JM. Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet 80: 650-663, 2008.
22. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005.
23. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, and Long F. Rac1 activation controls nuclear localization of β-catenin during canonical Wnt signaling. Cell 133: 340-353, 2008.
24. Zacco J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, and Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359: 1897-1908, 2008.
25. Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, and Dong C. Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol 27: 113-119, 2007.